摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-hydroxybenzyl)isoindoline-1,3-dione | 24124-24-1

中文名称
——
中文别名
——
英文名称
2-(4-hydroxybenzyl)isoindoline-1,3-dione
英文别名
2-(4-Hydroxybenzyl)isoindole-1,3-dione;2-[(4-hydroxyphenyl)methyl]isoindole-1,3-dione
2-(4-hydroxybenzyl)isoindoline-1,3-dione化学式
CAS
24124-24-1
化学式
C15H11NO3
mdl
——
分子量
253.257
InChiKey
OLOKGSWYKBEWSH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    57.6
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:1fed18fc44758914794d668824cef919
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and opioid activities of some naltrexone oxime ethers
    摘要:
    A series of alkyl, cycloalkyl, aryl, and aralkyl ethers of naltrexone oxime was prepared. The compounds were examined in binding assays for mu, delta and kappa opioid receptor affinity. In addition, the naltrexone oxime ethers were studied in animal models that measure opioid agonist and antagonist activity. These studies led to the discovery of several compounds, notably phenethyl 3e and phenylpropyl 3f ethers of naltrexone, which have a 10-fold increase in potency at the kappa opioid receptor with potent mu and kappa agonist properties in vivo.
    DOI:
    10.1016/0223-5234(94)90027-2
  • 作为产物:
    描述:
    4-((triisopropylsilyl)oxy)benzonitrile 在 palladium on activated charcoal 四丁基氟化铵氢气 作用下, 以 四氢呋喃甲苯 为溶剂, 25.0 ℃ 、344.73 kPa 条件下, 反应 23.0h, 生成 2-(4-hydroxybenzyl)isoindoline-1,3-dione
    参考文献:
    名称:
    Synthesis and opioid activities of some naltrexone oxime ethers
    摘要:
    A series of alkyl, cycloalkyl, aryl, and aralkyl ethers of naltrexone oxime was prepared. The compounds were examined in binding assays for mu, delta and kappa opioid receptor affinity. In addition, the naltrexone oxime ethers were studied in animal models that measure opioid agonist and antagonist activity. These studies led to the discovery of several compounds, notably phenethyl 3e and phenylpropyl 3f ethers of naltrexone, which have a 10-fold increase in potency at the kappa opioid receptor with potent mu and kappa agonist properties in vivo.
    DOI:
    10.1016/0223-5234(94)90027-2
点击查看最新优质反应信息

文献信息

  • Ru-Based Complexes as Heterogeneous Potential Catalysts for the Amidation of Aldehydes and Nitriles in Neat Water
    作者:Wael Abdelgayed Ahmed Arafa
    DOI:10.1246/bcsj.20200071
    日期:2020.9.15
    Abstract

    Five novel heterogeneous mononuclear complex-anchored Ru(III) have been efficiently sono-synthesized and characterized by utilizing several analytical techniques. The assembled complexes could be utilized as effective, robust and recyclable (up to eight consecutive runs) catalysts for one-pot transformation of a vast array of nitriles and aldehydes to primary amides in H2O under aerobic conditions. Moreover, some unreported di- and tetra-amide derivatives were obtained also under the optimal conditions. The results of ICP/OES analysis demonstrated that there is no detected leaching of the recycled catalyst, which suggests the real heterogeneity of the present protocol. The present Ru-complexes exhibited superiority compared to other reported catalysts for amide preparation in terms of low catalyst load, short reaction time, low operating temperature, no hazardous additives required, and high values of TON (990) and TOF (1980 h−1).

    摘要 利用多种分析技术高效地超声合成了五种新型异质单核络合物锚定 Ru(III),并对其进行了表征。在有条件下,这些组装好的配合物可作为有效、稳定和可循环(最多可连续运行八次)的催化剂,用于在 H2O 中将大量腈类和醛类化合物一锅转化为伯胺。此外,在最佳条件下还获得了一些未报道过的二酰胺和四酰胺生物。ICP/OES 分析结果表明,没有检测到回收催化剂的沥滤现象,这表明本方案具有真正的异质性。与其他已报道的酰胺制备催化剂相比,本发明的 Ru 复合物具有催化剂载量低、反应时间短、操作温度低、无需有害添加剂、TON 值(990)和 TOF 值(1980 h-1)高等优点。
  • [EN] COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME<br/>[FR] COMPOSITIONS PERMETTANT DE FAVORISER LA TRANSLECTURE DE CODONS DE TERMINAISON PRÉMATURÉE, ET LEURS PROCÉDÉS D'UTILISATION
    申请人:THE CENTRE FOR DRUG RES AND DEV
    公开号:WO2017049409A1
    公开(公告)日:2017-03-30
    Disclosed are compounds of general formula (I) that promote readthrough of a premature termination codon (PTC) of an RNA molecule in a translation system, and their use, alone or in combination with other compounds, such as aminoglycoside, to treat diseases or disorders ameliorated by modulation of a premature termination codon (PTC) of an RNA molecule in a translation system. The disorder or disease may be Dystrophic epidermolysis bullosa, Batten disease, Duchenne muscular dystrophy, cancer, and spinal muscular atrophy. Ar-L-B (I)
    公开了通式(I)的化合物,它们能够促进RNA分子在翻译系统中过早终止密码子(PTC)的通读,以及它们单独或与其他化合物如基糖苷的组合使用,用于治疗通过调节翻译系统中RNA分子的过早终止密码子(PTC)而得到改善的疾病或失调。该疾病或失调可能是营养不良性表皮松解症、贝敦病、杜氏肌营养不良症、癌症和脊髓性肌萎缩症。Ar-L-B (I)
  • 신규한 우레아 유도체 및 이의 용도
    申请人:Gwangju Institute of Science and Technology 광주과학기술원(319980993815) BRN ▼410-82-07550
    公开号:KR20210126975A
    公开(公告)日:2021-10-21
    본 발명은 신규한 우레아 유도체 화합물에 관한 것으로, 이의 5HT 길항제로서의 작용에 의한 신경정신장애, 퇴행성뇌질환, 전반발달장애 및/또는 대사성 질환의 예방 또는 치료 용도에 관한 것이다.
    本发明涉及一种新的尿素生物化合物,其用于预防或治疗神经精神障碍、退行性脑疾病、全身发育障碍和/或代谢性疾病,其作用为5HT拮抗剂
  • Efficient enhancement of DNA cleavage activity by introducing guanidinium groups into diiron(III) complex
    作者:Xiaoqiang Chen、Jingyun Wang、Shiguo Sun、Jiangli Fan、Song Wu、Jianfeng Liu、Saijian Ma、Lizhu Zhang、Xiaojun Peng
    DOI:10.1016/j.bmcl.2007.11.001
    日期:2008.1
    binuclear iron(III) systems. Compared with the corresponding analogue without guanidinium groups, the new diiron(III) system led to considerable rate enhancement on DNA cleavage. The cooperativity between metal ions and guanidine groups was evidenced by the fact that no significant cleavage was observed after incubating pBR322 plasmid DNA with non-metalated ligands or free Fe3+ ion. DNA binding experiments
    天然核酸酶结构的启发,将基引入双核(III)系统。与没有基的相应类似物相比,新的二价(III)系统显着提高了DNA切割的速率。通过将pBR322质粒DNA与非属化的配体或游离的Fe3 +离子孵育后,未观察到明显的裂解这一事实证明了属离子与基之间的协同作用。DNA结合实验表明,引入带正电荷的基可以使复合物与DNA的亲和力提高一个数量级以上。
  • Design, Synthesis, and Conformational Dynamics of a Gated Molecular Basket
    作者:Veselin Maslak、Zhiqing Yan、Shijing Xia、Judith Gallucci、Christopher M. Hadad、Jovica D. Badjić
    DOI:10.1021/ja060534l
    日期:2006.5.1
    and recognition properties of dynamic molecular containers 1-3. As follows from the 1H NMR dilution, diffusion NMR, and vapor pressure osmometry measurements, compound 1 has a low affinity for intermolecular aggregation and is mostly present in monomeric form in dilute chloroform solutions. Inspecting the O-H chemical shift resonances of 1, 3, and model compound 4 as a function of temperature afforded
    我们开发了一种合成方法并检查了动态分子容器 1-3 的构象行为和识别特性。根据 1H NMR 稀释、扩散 NMR 和蒸气压渗透压测量,化合物 1 对分子间聚集的亲和力较低,并且主要以单体形式存在于稀氯仿溶液中。检查 1、3 和模型化合物 4 的 OH 化学位移共振作为温度的函数,分别提供了 17.0、17.3 和 4.7 ppb K(-1) 的 delta delta/deltaT 系数。结合变温 1H NMR 和 IR 测量的结果,证实存在平衡的 1 和 3 构象异构体,每个构象异构体具有不同程度的键。分子力学计算表明 1a 是最有利的构象,与三个额外的构象异构体,1b、1c 和 1d,填充局部能量最小值。使用半经验 PM3 和 ab initio (HF/6-31G) 方法对四种构象异构体中的每一种进行进一步优化,可以确定它们的相对自由能和相应的玻尔兹曼分布,这些分布对 1a 有很大的权重。1
查看更多

同类化合物

(1Z,3Z)-1,3-双[[((4S)-4,5-二氢-4-苯基-2-恶唑基]亚甲基]-2,3-二氢-5,6-二甲基-1H-异吲哚 鲁拉西酮杂质33 鲁拉西酮杂质07 马吲哚 颜料黄110 顺式-六氢异吲哚盐酸盐 顺式-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]-N-乙基-1-苯基环丙烷甲酰胺 顺式-2,3,3a,4,7,7a-六氢-1H-异吲哚 顺-N-(4-氯丁烯基)邻苯二甲酰亚胺 降莰烷-2,3-二甲酰亚胺 降冰片烯-2,3-二羧基亚胺基对硝基苄基碳酸酯 降冰片烯-2,3-二羧基亚胺基叔丁基碳酸酯 阿胍诺定 阿普斯特降解杂质 阿普斯特杂质FA 阿普斯特杂质68 阿普斯特杂质29 阿普斯特杂质27 阿普斯特杂质26 阿普斯特杂质19 阿普斯特杂质08 阿普斯特杂质03 阿普斯特杂质 阿普斯特二聚体杂质 阿普斯特 防焦剂MTP 铝酞菁 铁(II)1,2,3,4,8,9,10,11,15,16,17,18,22,23,24,25-十六氟-29H,31H-酞菁 铁(II)2,9,16,23-四氨基酞菁 钠S-(2-{[2-(1,3-二氧代-1,3-二氢-2H-异吲哚-2-基)乙基]氨基}乙基)氢硫代磷酸酯 酞酰亚胺-15N钾盐 酞菁锡 酞菁二氯化硅 酞菁 单氯化镓(III) 盐 酞美普林 邻苯二甲酸亚胺 邻苯二甲酰基氨氯地平 邻苯二甲酰亚胺,N-((吗啉)甲基) 邻苯二甲酰亚胺阴离子 邻苯二甲酰亚胺钾盐 邻苯二甲酰亚胺钠盐 邻苯二甲酰亚胺观盐 邻苯二亚胺甲基磷酸二乙酯 那伏莫德 过氧化氢,2,5-二氢-5-苯基-3H-咪唑并[2,1-a]异吲哚-5-基 达格吡酮 诺非卡尼 螺[环丙烷-1,1'-异二氢吲哚]-3'-酮 螺[异吲哚啉-1,4'-哌啶]-3-酮盐酸盐 葡聚糖凝胶G-25